1,442 reports of this reaction
9.1% of all BUPRENORPHINE HYDROCHLORIDE reports
#2 most reported adverse reaction
OVERDOSE is the #2 most commonly reported adverse reaction for BUPRENORPHINE HYDROCHLORIDE, manufactured by BioDelivery Sciences International Inc. There are 1,442 FDA adverse event reports linking BUPRENORPHINE HYDROCHLORIDE to OVERDOSE. This represents approximately 9.1% of all 15,869 adverse event reports for this drug.
Patients taking BUPRENORPHINE HYDROCHLORIDE who experience overdose should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
OVERDOSE is moderately reported among BUPRENORPHINE HYDROCHLORIDE users, representing a notable but not dominant share of adverse events.
In addition to overdose, the following adverse reactions have been reported for BUPRENORPHINE HYDROCHLORIDE:
The following drugs have also been linked to overdose in FDA adverse event reports:
OVERDOSE has been reported as an adverse event in 1,442 FDA reports for BUPRENORPHINE HYDROCHLORIDE. This does not prove causation, but indicates an association observed in post-market surveillance data.
OVERDOSE accounts for approximately 9.1% of all adverse event reports for BUPRENORPHINE HYDROCHLORIDE, making it one of the most commonly reported side effect.
If you experience overdose while taking BUPRENORPHINE HYDROCHLORIDE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.